3-OH-kynurenine
metaboliteA kynurenine-pathway metabolite reflecting tryptophan catabolism and ischemic myocardial injury in Type 1 MI.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleKynurenine-pathway intermediate elevated in STEMI; reflects myocardial injury.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(1)
- Targeted metabolomic profiling of acute ST-segment elevation myocardial infarction.Scientific reports · 2024 · PMID 39394398 · doi